Published June 2013 • Catalog no. ATR987K • Price US $2,850
The ability to isolate, purify and re-inject patient-derived cells with regenerative properties has led to a number of therapeutic products for the treatment of refractory injuries and wounds. Autologous tissue repair is having an impact on a number of areas, including cardiovascular medicine, refractory wound care, orthopedics, and surgical medicine. The potential economic benefits of autologous tissue repair are significant, as an aging population struggles with intractable ailments that historically have required numerous follow-up provider visits. While several autologous therapies require remote processing, the number of therapeutic autologous products that can be processed at the point-of-care is increasing. This report details the autologous tissue repair products and development programs of twenty-seven separate companies in seven countries – companies working to shape the future of tissue regeneration.
Autologous Tissue Repair – Report Prospectus (Download PDF)
Autologous Tissue Repair Order Form (Download PDF)
Highlights
· Analyzes and evaluates autologous tissue repair products and product candidates and assesses the market potential for existing and probable future products
· Examines tissue repair demand drivers and evolving market factors
· Forecasts the impact of tissue regeneration technology and therapeutics on application segments and projects probable future developments
· Profiles autologous tissue repair market participants, their technology, product development activity, and business strategies
Summary of Contents
Executive Summary
Autologous Tissue Repair – Market Structure
Tissue Repair Market Segments
Demographics and Growth
Competitive Landscape
Demand Drivers
Risk Factors
Therapeutic Application Segment Analysis
CNS
Orthopedic
Bone Graft Fixation
Ligament Repair
Surgical
Cardiovascular Procedures
Neurosurgical Procedures
Plastic/Cosmetic Surgery
Wound Care
Acute Trauma
Burns
Diabetic Ulcers
Pressure Ulcers
Venous Ulcers
Autologous Therapeutics – Product Analysis, Outlook and Forecasts
Chondrocyte Harvesting
Cardiovascular Grafts
Epidermal Grafts
Macrophage Activation
Skin Cell Suspension
Thrombin/Platelet Gels
Platelet Rich Plasma
Stem Cell Isolation
Market Factors
Clinical Trial Enrollment
FDA Guidelines
Reimbursement
Evolving Patient Demographics
Point-of-Care Processing
Protocols and End-Points
Autologous Tissue Repair Company Profiles